Stocks and Investing Stocks and Investing
Mon, March 4, 2024
Fri, March 1, 2024

Michael Petusky Reiterated (XRAY) at Buy and Held Target at $41 on, Mar 1st, 2024


Published on 2024-10-28 09:23:56 - WOPRAI, Michael Petusky
  Print publication without navigation


Michael Petusky of Barrington Research, Reiterated "DENTSPLY SIRONA Inc." (XRAY) at Buy and Held Target at $41 on, Mar 1st, 2024.

Michael has made no other calls on XRAY in the last 4 months.



There are 7 other peers that have a rating on XRAY. Out of the 7 peers that are also analyzing XRAY, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Bednar of "Piper Sandler" Maintained at Hold with Increased Target to $35 on, Friday, January 12th, 2024
  • Jonathan Block of "Stifel" Maintained at Hold with Decreased Target to $32 on, Monday, November 13th, 2023
  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $36 on, Tuesday, November 7th, 2023


These are the ratings of the 4 analyists that currently disagree with Michael


  • David Saxon of "Needham" Reiterated at Strong Buy and Held Target at $42 on, Thursday, February 29th, 2024
  • Michael Cherny of "Leerink Partners" Initiated at Buy and Held Target at $42 on, Monday, February 26th, 2024
  • Brandon Vazquez of "William Blair" Upgraded from Hold to Buy on, Friday, November 10th, 2023
  • Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Friday, November 3rd, 2023